Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Oct;55(10):715–722. doi: 10.1136/ard.55.10.715

Novel pharmacological strategies for analgesia.

M Perkins 1, A Dray 1
PMCID: PMC1010286  PMID: 8984935

Full text

PDF
715

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aanonsen L. M., Wilcox G. L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther. 1987 Oct;243(1):9–19. [PubMed] [Google Scholar]
  2. Aimi Y., Fujimura M., Vincent S. R., Kimura H. Localization of NADPH-diaphorase-containing neurons in sensory ganglia of the rat. J Comp Neurol. 1991 Apr 15;306(3):382–392. doi: 10.1002/cne.903060303. [DOI] [PubMed] [Google Scholar]
  3. Ault B., Hildebrand L. M. Activation of nociceptive reflexes by peripheral kainate receptors. J Pharmacol Exp Ther. 1993 May;265(2):927–932. [PubMed] [Google Scholar]
  4. Babbedge R. C., Bland-Ward P. A., Hart S. L., Moore P. K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol. 1993 Sep;110(1):225–228. doi: 10.1111/j.1476-5381.1993.tb13796.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Babbedge R. C., Wallace P., Gaffen Z. A., Hart S. L., Moore P. K. L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse. Neuroreport. 1993 Mar;4(3):307–310. doi: 10.1097/00001756-199303000-00020. [DOI] [PubMed] [Google Scholar]
  6. Bhoola K. D., Figueroa C. D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992 Mar;44(1):1–80. [PubMed] [Google Scholar]
  7. Birch P. J., Harrison S. M., Hayes A. G., Rogers H., Tyers M. B. The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br J Pharmacol. 1992 Mar;105(3):508–510. doi: 10.1111/j.1476-5381.1992.tb09008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Birrell G. J., McQueen D. S., Iggo A., Grubb B. D. Prostanoid-induced potentiation of the excitatory and sensitizing effects of bradykinin on articular mechanonociceptors in the rat ankle joint. Neuroscience. 1993 May;54(2):537–544. doi: 10.1016/0306-4522(93)90273-i. [DOI] [PubMed] [Google Scholar]
  9. Brand L., Berman E., Schwen R., Loomans M., Janusz J., Bohne R., Maddin C., Gardner J., Lahann T., Farmer R. NE-19550: a novel, orally active anti-inflammatory analgesic. Drugs Exp Clin Res. 1987;13(5):259–265. [PubMed] [Google Scholar]
  10. Burgess G. M., Mullaney I., McNeill M., Dunn P. M., Rang H. P. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J Neurosci. 1989 Sep;9(9):3314–3325. doi: 10.1523/JNEUROSCI.09-09-03314.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cahusac P. M., Evans R. H., Hill R. G., Rodriquez R. E., Smith D. A. The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 1984 Jul;23(7A):719–724. doi: 10.1016/0028-3908(84)90102-3. [DOI] [PubMed] [Google Scholar]
  12. Chanmugam P., Feng L., Liou S., Jang B. C., Boudreau M., Yu G., Lee J. H., Kwon H. J., Beppu T., Yoshida M. Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J Biol Chem. 1995 Mar 10;270(10):5418–5426. doi: 10.1074/jbc.270.10.5418. [DOI] [PubMed] [Google Scholar]
  13. Cheshire W. P., Snyder C. R. Treatment of reflex sympathetic dystrophy with topical capsaicin. Case report. Pain. 1990 Sep;42(3):307–311. doi: 10.1016/0304-3959(90)91143-7. [DOI] [PubMed] [Google Scholar]
  14. Corrêa C. R., Calixto J. B. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol. 1993 Sep;110(1):193–198. doi: 10.1111/j.1476-5381.1993.tb13791.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain. 1994 May;57(2):153–160. doi: 10.1016/0304-3959(94)90218-6. [DOI] [PubMed] [Google Scholar]
  16. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 1991 Jul 12;553(2):327–330. doi: 10.1016/0006-8993(91)90844-l. [DOI] [PubMed] [Google Scholar]
  17. Davis A. J., Kelly D., Perkins M. N. The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli. Braz J Med Biol Res. 1994 Aug;27(8):1793–1802. [PubMed] [Google Scholar]
  18. Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol. 1992 Aug 18;44(4):611–615. doi: 10.1016/0006-2952(92)90393-w. [DOI] [PubMed] [Google Scholar]
  19. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993 Mar;16(3):99–104. doi: 10.1016/0166-2236(93)90133-7. [DOI] [PubMed] [Google Scholar]
  20. Dray A., Urban L., Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sci. 1994 Jun;15(6):190–197. doi: 10.1016/0165-6147(94)90147-3. [DOI] [PubMed] [Google Scholar]
  21. Dun N. J., Dun S. L., Wu S. Y., Förstermann U., Schmidt H. H., Tseng L. F. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience. 1993 Jun;54(4):845–857. doi: 10.1016/0306-4522(93)90579-5. [DOI] [PubMed] [Google Scholar]
  22. Eisenberg E., Vos B. P., Strassman A. M. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain. 1993 Sep;54(3):301–307. doi: 10.1016/0304-3959(93)90029-O. [DOI] [PubMed] [Google Scholar]
  23. Endo T., Ogushi F., Sone S., Ogura T., Taketani Y., Hayashi Y., Ueda N., Yamamoto S. Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. Am J Respir Cell Mol Biol. 1995 Mar;12(3):358–365. doi: 10.1165/ajrcmb.12.3.7873203. [DOI] [PubMed] [Google Scholar]
  24. Galizzi J. P., Bodinier M. C., Chapelain B., Ly S. M., Coussy L., Giraud S., Neliat G., Jean T. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Br J Pharmacol. 1994 Oct;113(2):389–394. doi: 10.1111/j.1476-5381.1994.tb17001.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Haley J. E., Dickenson A. H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 1992 Mar;31(3):251–258. doi: 10.1016/0028-3908(92)90175-o. [DOI] [PubMed] [Google Scholar]
  26. Haley J. E., Sullivan A. F., Dickenson A. H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 1990 Jun 4;518(1-2):218–226. doi: 10.1016/0006-8993(90)90975-h. [DOI] [PubMed] [Google Scholar]
  27. Hall J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131–190. doi: 10.1016/0163-7258(92)90016-s. [DOI] [PubMed] [Google Scholar]
  28. Hayes A. G., Skingle M., Tyers M. B. Effects of single doses of capsaicin on nociceptive thresholds in the rodent. Neuropharmacology. 1981 May;20(5):505–511. doi: 10.1016/0028-3908(81)90185-4. [DOI] [PubMed] [Google Scholar]
  29. Heapy C. G., Shaw J. S., Farmer S. C. Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140. Br J Pharmacol. 1993 Jan;108(1):209–213. doi: 10.1111/j.1476-5381.1993.tb13464.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hess J. F., Borkowski J. A., Young G. S., Strader C. D., Ransom R. W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992 Apr 15;184(1):260–268. doi: 10.1016/0006-291x(92)91187-u. [DOI] [PubMed] [Google Scholar]
  31. Hock F. J., Wirth K., Albus U., Linz W., Gerhards H. J., Wiemer G., Henke S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol. 1991 Mar;102(3):769–773. doi: 10.1111/j.1476-5381.1991.tb12248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Holthusen H., Arndt J. O. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett. 1994 Jan 3;165(1-2):71–74. doi: 10.1016/0304-3940(94)90712-9. [DOI] [PubMed] [Google Scholar]
  33. Kawabata A., Umeda N., Takagi H. L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol. 1993 May;109(1):73–79. doi: 10.1111/j.1476-5381.1993.tb13533.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Khan A. A., Raja S. N., Manning D. C., Campbell J. N., Meyer R. A. The effects of bradykinin and sequence-related analogs on the response properties of cutaneous nociceptors in monkeys. Somatosens Mot Res. 1992;9(2):97–106. doi: 10.3109/08990229209144765. [DOI] [PubMed] [Google Scholar]
  35. Khasar S. G., Green P. G., Levine J. D. Comparison of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the rat. Neurosci Lett. 1993 Apr 30;153(2):215–218. doi: 10.1016/0304-3940(93)90325-f. [DOI] [PubMed] [Google Scholar]
  36. Kindgen-Milles D., Klement W. Pain and inflammation evoked in human skin by bradykinin receptor antagonists. Eur J Pharmacol. 1992 Jul 21;218(1):183–185. doi: 10.1016/0014-2999(92)90164-y. [DOI] [PubMed] [Google Scholar]
  37. Kristensen J. D., Karlsten R., Gordh T., Berge O. G. The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat. Pain. 1994 Jan;56(1):59–67. doi: 10.1016/0304-3959(94)90150-3. [DOI] [PubMed] [Google Scholar]
  38. Kristensen J. D., Svensson B., Gordh T., Jr The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain. 1992 Nov;51(2):249–253. doi: 10.1016/0304-3959(92)90266-E. [DOI] [PubMed] [Google Scholar]
  39. Kumar A., Raghubir R., Srimal R. C., Dhawan B. N. Evidence for involvement of nitric oxide in pretectal analgesia in rat. Neuroreport. 1993 Jun;4(6):706–708. doi: 10.1097/00001756-199306000-00026. [DOI] [PubMed] [Google Scholar]
  40. Lamas S., Marsden P. A., Li G. K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6348–6352. doi: 10.1073/pnas.89.14.6348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lerner U. H., Modéer T. Bradykinin B1 and B2 receptor agonists synergistically potentiate interleukin-1-induced prostaglandin biosynthesis in human gingival fibroblasts. Inflammation. 1991 Dec;15(6):427–436. doi: 10.1007/BF00923340. [DOI] [PubMed] [Google Scholar]
  42. Levine J. D., Fields H. L., Basbaum A. I. Peptides and the primary afferent nociceptor. J Neurosci. 1993 Jun;13(6):2273–2286. doi: 10.1523/JNEUROSCI.13-06-02273.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lynn B. Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain. 1990 Apr;41(1):61–69. doi: 10.1016/0304-3959(90)91110-5. [DOI] [PubMed] [Google Scholar]
  44. Maggi C. A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol. 1993 Feb;13(1):23–93. doi: 10.1111/j.1474-8673.1993.tb00396.x. [DOI] [PubMed] [Google Scholar]
  45. Mao J., Price D. D., Mayer D. J., Lu J., Hayes R. L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 1992 Apr 3;576(2):254–262. doi: 10.1016/0006-8993(92)90688-6. [DOI] [PubMed] [Google Scholar]
  46. Masferrer J. L., Zweifel B. S., Manning P. T., Hauser S. D., Leahy K. M., Smith W. G., Isakson P. C., Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3228–3232. doi: 10.1073/pnas.91.8.3228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. McEachern A. E., Shelton E. R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R. W., Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7724–7728. doi: 10.1073/pnas.88.17.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Meller S. T., Cummings C. P., Traub R. J., Gebhart G. F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 1994 May;60(2):367–374. doi: 10.1016/0306-4522(94)90250-x. [DOI] [PubMed] [Google Scholar]
  49. Meller S. T., Pechman P. S., Gebhart G. F., Maves T. J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 1992 Sep;50(1):7–10. doi: 10.1016/0306-4522(92)90377-e. [DOI] [PubMed] [Google Scholar]
  50. Menke J. G., Borkowski J. A., Bierilo K. K., MacNeil T., Derrick A. W., Schneck K. A., Ransom R. W., Strader C. D., Linemeyer D. L., Hess J. F. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994 Aug 26;269(34):21583–21586. [PubMed] [Google Scholar]
  51. Minc-Golomb D., Tsarfaty I., Schwartz J. P. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br J Pharmacol. 1994 Jul;112(3):720–722. doi: 10.1111/j.1476-5381.1994.tb13136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693–11697. doi: 10.1073/pnas.90.24.11693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Mitchell J. A., Belvisi M. G., Akarasereenont P., Robbins R. A., Kwon O. J., Croxtall J., Barnes P. J., Vane J. R. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994 Nov;113(3):1008–1014. doi: 10.1111/j.1476-5381.1994.tb17093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mizumura K., Minagawa M., Tsujii Y., Kumazawa T. The effects of bradykinin agonists and antagonists on visceral polymodal receptor activities. Pain. 1990 Feb;40(2):221–227. doi: 10.1016/0304-3959(90)90072-L. [DOI] [PubMed] [Google Scholar]
  55. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  56. Moore P. K., Babbedge R. C., Wallace P., Gaffen Z. A., Hart S. L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol. 1993 Feb;108(2):296–297. doi: 10.1111/j.1476-5381.1993.tb12798.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Moore P. K., Oluyomi A. O., Babbedge R. C., Wallace P., Hart S. L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol. 1991 Jan;102(1):198–202. doi: 10.1111/j.1476-5381.1991.tb12153.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Munro F. E., Fleetwood-Walker S. M., Parker R. M., Mitchell R. The effects of neurokinin receptor antagonists on mustard oil-evoked activation of rat dorsal horn neurons. Neuropeptides. 1993 Nov;25(5):299–305. doi: 10.1016/0143-4179(93)90047-e. [DOI] [PubMed] [Google Scholar]
  59. Murphy S., Simmons M. L., Agullo L., Garcia A., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., Schwartz J. P. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 1993 Aug;16(8):323–328. doi: 10.1016/0166-2236(93)90109-y. [DOI] [PubMed] [Google Scholar]
  60. Perkins M. N., Campbell E., Dray A. Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain. 1993 May;53(2):191–197. doi: 10.1016/0304-3959(93)90080-9. [DOI] [PubMed] [Google Scholar]
  61. Perkins M. N., Kelly D. Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br J Pharmacol. 1993 Dec;110(4):1441–1444. doi: 10.1111/j.1476-5381.1993.tb13982.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Rang H. P., Bevan S., Dray A. Chemical activation of nociceptive peripheral neurones. Br Med Bull. 1991 Jul;47(3):534–548. doi: 10.1093/oxfordjournals.bmb.a072491. [DOI] [PubMed] [Google Scholar]
  63. Ren K., Hylden J. L., Williams G. M., Ruda M. A., Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 1992 Sep;50(3):331–344. doi: 10.1016/0304-3959(92)90039-E. [DOI] [PubMed] [Google Scholar]
  64. Ren K., Williams G. M., Hylden J. L., Ruda M. A., Dubner R. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur J Pharmacol. 1992 Aug 25;219(2):235–243. doi: 10.1016/0014-2999(92)90301-j. [DOI] [PubMed] [Google Scholar]
  65. Ren K., Williams G. M., Ruda M. A., Dubner R. Inflammation and hyperalgesia in rats neonatally treated with capsaicin: effects on two classes of nociceptive neurons in the superficial dorsal horn. Pain. 1994 Nov;59(2):287–300. doi: 10.1016/0304-3959(94)90082-5. [DOI] [PubMed] [Google Scholar]
  66. Rueff A., Dray A. Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience. 1993 May;54(2):527–535. doi: 10.1016/0306-4522(93)90272-h. [DOI] [PubMed] [Google Scholar]
  67. Seibert K., Masferrer J. L. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor. 1994 Spring;4(1):17–23. [PubMed] [Google Scholar]
  68. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12013–12017. doi: 10.1073/pnas.91.25.12013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sengupta J. N., Gebhart G. F. Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat. J Neurophysiol. 1994 Jun;71(6):2046–2060. doi: 10.1152/jn.1994.71.6.2046. [DOI] [PubMed] [Google Scholar]
  70. Sietsema W. K., Berman E. F., Farmer R. W., Maddin C. S. The antinociceptive effect and pharmacokinetics of olvanil following oral and subcutaneous dosing in the mouse. Life Sci. 1988;43(17):1385–1391. doi: 10.1016/0024-3205(88)90305-0. [DOI] [PubMed] [Google Scholar]
  71. Steranka L. R., Manning D. C., DeHaas C. J., Ferkany J. W., Borosky S. A., Connor J. R., Vavrek R. J., Stewart J. M., Snyder S. H. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A. 1988 May;85(9):3245–3249. doi: 10.1073/pnas.85.9.3245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Takagi H., Shiomi H., Ueda H., Amano H. A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser. Nature. 1979 Nov 22;282(5737):410–412. doi: 10.1038/282410a0. [DOI] [PubMed] [Google Scholar]
  73. Tomlinson A., Appleton I., Moore A. R., Gilroy D. W., Willis D., Mitchell J. A., Willoughby D. A. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol. 1994 Nov;113(3):693–698. doi: 10.1111/j.1476-5381.1994.tb17048.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Tonussi C. R., Ferreira S. H. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur J Pharmacol. 1994 Jan 14;251(2-3):173–179. doi: 10.1016/0014-2999(94)90398-0. [DOI] [PubMed] [Google Scholar]
  75. Urban L., Thompson S. W., Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci. 1994 Oct;17(10):432–438. doi: 10.1016/0166-2236(94)90018-3. [DOI] [PubMed] [Google Scholar]
  76. Vasko M. R., Campbell W. B., Waite K. J. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci. 1994 Aug;14(8):4987–4997. doi: 10.1523/JNEUROSCI.14-08-04987.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Verge V. M., Xu Z., Xu X. J., Wiesenfeld-Hallin Z., Hökfelt T. Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11617–11621. doi: 10.1073/pnas.89.23.11617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Von Korff M., Dworkin S. F., Le Resche L. Graded chronic pain status: an epidemiologic evaluation. Pain. 1990 Mar;40(3):279–291. doi: 10.1016/0304-3959(90)91125-3. [DOI] [PubMed] [Google Scholar]
  79. Watson C. P., Evans R. J. The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain. 1992 Dec;51(3):375–379. doi: 10.1016/0304-3959(92)90223-X. [DOI] [PubMed] [Google Scholar]
  80. Watson C. P., Tyler K. L., Bickers D. R., Millikan L. E., Smith S., Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993 May-Jun;15(3):510–526. [PubMed] [Google Scholar]
  81. Whalley E. T., Clegg S., Stewart J. M., Vavrek R. J. The effect of kinin agonists and antagonists on the pain response of the human blister base. Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):652–655. doi: 10.1007/BF00165756. [DOI] [PubMed] [Google Scholar]
  82. Wiesenfeld-Hallin Z., Hao J. X., Xu X. J., Hökfelt T. Nitric oxide mediates ongoing discharges in dorsal root ganglion cells after peripheral nerve injury. J Neurophysiol. 1993 Dec;70(6):2350–2353. doi: 10.1152/jn.1993.70.6.2350. [DOI] [PubMed] [Google Scholar]
  83. Wright J. M. Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy. 1994 Nov-Dec;14(6):689–697. [PubMed] [Google Scholar]
  84. Xie W. L., Chipman J. G., Robertson D. L., Erikson R. L., Simmons D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2692–2696. doi: 10.1073/pnas.88.7.2692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Xu J. Y., Tseng L. F. Increase of nitric oxide by L-arginine potentiates beta-endorphin- but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse. Eur J Pharmacol. 1993 May 12;236(1):137–142. doi: 10.1016/0014-2999(93)90236-b. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES